Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
NeoOVIV vaccine (West China Hospital) in Ovarian Cancer: NCT07676890 Clinical Landscape Report 2026
16 September 2026
NCT07676890 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RD-0605 in Idiopathic Inflammatory Myopathies: NCT07674147 Clinical Landscape Report 2026
16 September 2026
NCT07674147 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Dacarbazine in Melanoma, Cutaneous Malignant: NCT07671495 Clinical Landscape Report 2026
16 September 2026
NCT07671495 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Lupus Nephritis: NCT07678203 Clinical Landscape Report 2026
16 September 2026
NCT07678203 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxychloroquine Sulfate in Lupus Nephritis: NCT07675291 Clinical Landscape Report 2026
16 September 2026
NCT07675291 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Donepezil Hydrochloride in Alzheimer Disease: NCT07680660 Clinical Landscape Report 2026
16 September 2026
NCT07680660 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07688980 Clinical Landscape Report 2026
16 September 2026
NCT07688980 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Psoriasis vulgaris: CTRI/2026/07/113498 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/07/113498 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lecanemab in Alzheimer Disease: NCT07688460 Clinical Landscape Report 2026
16 September 2026
NCT07688460 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
225Ac-PD-32766 in Renal Cell Carcinoma: NCT07688187 Clinical Landscape Report 2026
16 September 2026
NCT07688187 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lisaftoclax in Acute Myeloid Leukemia: NCT07686965 Clinical Landscape Report 2026
16 September 2026
NCT07686965 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Acute Myeloid Leukemia: NCT07686107 Clinical Landscape Report 2026
16 September 2026
NCT07686107 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.